(Posted more for Mason and Wombat to chew over and consider as they seem to collate all the interesting work)
If RAC wants to use Zantrene as a CPI enhancer rather than a chemotherapy agent (effectively giving a patient 2 CPI's) they still need to partner with a T-cell therapy company as the results in this study are not good enough and have been well overtaken by CPI plus oncolytic viral approaches. The COH paper used activated T-cells and Zantrene (without anti- PD-1) to get the excellent responses they published. I have been waiting for the penny to drop with management (or at least for them to publically acknowledge the point). Simply put, the immune activation (rather than the CPI effect) seen from Zantrene is not sufficient to avoid another combinatorial approach. Lots to choose from.
The next set of pre-clin could compare PD-1 to Zantrene with and without a t-cell approach and see what is what.
Interestingly the COH paper showed that Zantrene acted as a CTLA inhibitor (as against PD-1).
The renal cell data released a few weeks ago was also interesting but I noted that the concentration to kill some of the cancer cell lines was very similar to that which also killed the normal kidney cell line.
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-63
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.035(2.27%) |
Mkt cap ! $270.1M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.55 | $149.9K | 95.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5850 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 850 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5850 | 1.575 |
2 | 16186 | 1.570 |
3 | 11135 | 1.560 |
4 | 35331 | 1.550 |
1 | 700 | 1.520 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 850 | 1 |
1.590 | 2783 | 2 |
1.595 | 5305 | 1 |
1.600 | 12088 | 2 |
1.610 | 622 | 1 |
Last trade - 15.32pm 10/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online